JLHLBSEJupiter Life Line Hospitals Ltd· Healthcare ServicesHighNeutral
Announced Fri, 15 May, 2026 · 19:11 IST

Record Date for Declaration of Interim Dividend

Revenue Growth 20pctExceptional ItemResults View source PDFExplain this filing

JLHL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+0.6%Reaction day
₹1323.00
prior close
₹1335.00
announcement price
After-mkt
timing
Nifty Microcap 250market · index membership as recorded later (tracked since Jun 2026)-1.4%+2.0% vs market
Hospital peers, median of 26sector-0.5%+1.1% vs sector

On the reaction day the stock moved 2.0 pts more than Nifty Microcap 250 and 1.1 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-1.9
10m
-2.2
15m
-2.6
30m
-2.9
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+0.6-1.4+2.0-0.5+1.1
Next day
+1.2-0.9+2.1+0.7+0.5
2d
-0.2-0.3+0.2+0.2-0.4
3d
-1.2+0.8-2.0+0.8-2.0
4d
+2.7+0.9+1.9+0.2+2.5
5d
+2.6+2.5+0.2+1.0+1.6
1w
+0.2+3.1-3.0+1.0-0.8
15d
+1.5+3.5-1.9+2.2-0.7
1m
+1.9+8.0-6.1+3.2-1.3
2m
+17.8+9.3+8.5+4.7+13.0
3m
—+14.0—+7.9—
UpDownMarket · Nifty Microcap 250Sector · Hospital peers, median of 26Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Jupiter Life Line Hospitals reported audited FY2026 consolidated revenue of Rs. 14,997.87 million, up 15.2% from Rs. 13,024.02 million in FY2025. Profit after tax remained relatively flat at Rs. 1,941.87 million vs Rs. 1,937.54 million previously. The Board declared an interim dividend of 10% (Rs. 1 per share) with record date May 22, 2026, and approved a stock split dividing each Rs. 10 share into 5 shares of Rs. 2 each to improve liquidity. Joint statutory auditors issued an unmodified (clean) opinion on both standalone and consolidated results. Management appointments include Dr. Ajay Thakker as Chairman & Whole-Time Director and new internal and cost auditors for FY2026-27.

Likely market impact

The stock split and dividend signal management confidence, though flat PAT growth may temper near-term enthusiasm. Clean audit opinion removes concern about financial reporting quality. The split could improve retail participation and liquidity.